UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1066-1072

2008

Volltextzugriff (PDF)

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R1186-R1198, Article R1186

2005

Volltextzugriff (PDF)

Cancer therapy using a self-replicating RNA vaccine

Nature medicine, 1999-07, Vol.5 (7), p.823-827

1999

Volltextzugriff (PDF)

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1938-1949

2010

Volltextzugriff (PDF)

Cancer cell lines as genetic models of their parent histology : Analyses based on array comparative genomic hybridization

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3594-3600

2007

Volltextzugriff (PDF)

Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors

Investigational new drugs, 2012-04, Vol.30 (2), p.695-701

2012

Volltextzugriff (PDF)

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors

Cancer research (Chicago, Ill.), 1998-11, Vol.58 (21), p.4902-4908

1998

Volltextzugriff (PDF)

INDUCTION OF PROINFLAMMATORY AND CHEMOKINE GENES BY LIPOPOLYSACCHARIDE AND PACLITAXEL (Taxol™) IN MURINE AND HUMAN BREAST CANCER CELL LINES

Cytokine (Philadelphia, Pa.), 2001-08, Vol.15 (3), p.156-165

2001

Volltextzugriff (PDF)

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

Cancer research (Chicago, Ill.), 1999, Vol.59 (1), p.59-62

1999

Volltextzugriff (PDF)

Fas-Mediated Suicide of Tumor-Reactive T Cells Following Activation by Specific Tumor: Selective Rescue by Caspase Inhibition

The Journal of immunology (1950), 1999-03, Vol.162 (6), p.3273-3279

1999

Volltextzugriff (PDF)

Immunogenicity and tolerability of personalized mRNA vaccine mRNA-4650 encoding defined neoantigens expressed by the autologous cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2643-2643

2019

Volltextzugriff (PDF)

T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle

Molecular biology of the cell, 1999-12, Vol.10 (12), p.4441-4450

1999

Volltextzugriff (PDF)

A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2523-2523

2019

Volltextzugriff (PDF)

TCR stimulation protects CD8 + T cells from CD95 mediated apoptosis

Human immunology, 2001, Vol.62 (1), p.32-38

2001

Volltextzugriff (PDF)

Are Patient or Disease Characteristics Associated with Complete Response or Progression During Bendamustine-Rituximab Treatment in Previously Treated Patients with Non-Hodgkin's Lymphoma?

Blood, 2009-11, Vol.114 (22), p.5002-5002

2009

Volltextzugriff (PDF)

IVIG therapy for platelet refractoriness due to HLA class I antibodies: a case report

Human immunology, 2003-10, Vol.64 (10), p.S72-S72

2003

Volltextzugriff (PDF)

O25: Analysis of the genetic similarity of 10 cancer types using genome copy number data

European journal of medical genetics, 2005-10, Vol.48 (4), p.492-493

2005

Volltextzugriff (PDF)

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Nature medicine, 2021-12, Vol.27 (12), p.2224-2233

2021

Volltextzugriff (PDF)

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Nature medicine, 2022-05, Vol.28 (5), p.1095-1096

2022

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(12)
Oncology
(7)
Tumor Cells, Cultured
(6)
Adult
(5)
Biological And Medical Sciences
(5)
Female
(5)
Medical Sciences
(5)
Antineoplastic Agents
(4)
Cell Biology
(4)
Middle Aged
(4)
Pharmacology. Drug Treatments
(4)
Aged
(3)
Biochemistry & Molecular Biology
(3)
Cd8-Positive T-Lymphocytes - Immunology
(3)
Fas Ligand Protein
(3)
Immunology
(3)
Receptor, Erbb-2 - Antagonists & Inhibitors
(3)
Receptor, Erbb-2 - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Cancer therapy using a self-replicating RNA vaccine

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer cell lines as genetic models of their parent histology : Analyses based on array comparative genomic hybridization

Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors

INDUCTION OF PROINFLAMMATORY AND CHEMOKINE GENES BY LIPOPOLYSACCHARIDE AND PACLITAXEL (Taxol™) IN MURINE AND HUMAN BREAST CANCER CELL LINES

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

Fas-Mediated Suicide of Tumor-Reactive T Cells Following Activation by Specific Tumor: Selective Rescue by Caspase Inhibition

Immunogenicity and tolerability of personalized mRNA vaccine mRNA-4650 encoding defined neoantigens expressed by the autologous cancer

T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle

A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors

TCR stimulation protects CD8 + T cells from CD95 mediated apoptosis

Are Patient or Disease Characteristics Associated with Complete Response or Progression During Bendamustine-Rituximab Treatment in Previously Treated Patients with Non-Hodgkin's Lymphoma?

IVIG therapy for platelet refractoriness due to HLA class I antibodies: a case report

A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603)

O25: Analysis of the genetic similarity of 10 cancer types using genome copy number data

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Suchergebnisse filtern